Related references
Note: Only part of the references are listed.Everyone has a donor: contribution of the Chinese experience to global practice of haploidentical hematopoietic stem cell transplantation
Meng Lv et al.
FRONTIERS OF MEDICINE (2019)
Low-dose post-transplant cyclophosphamide and anti-thymocyte globulin as an effective strategy for GVHD prevention in haploidentical patients
Yu Wang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Predictive value of disease risk comorbidity index for overall survival after allogeneic hematopoietic transplantation
Nelli Bejanyan et al.
BLOOD ADVANCES (2019)
Impact of HLA allele mismatch at HLA-A, -B, -C,-DRB1, and-DQB1 on outcomes in haploidentical stem cell transplantation
Ming-Rui Huo et al.
BONE MARROW TRANSPLANTATION (2018)
The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China-recommendations from the Chinese Society of Hematology
Lanping Xu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
The consensus on the monitoring, treatment, and prevention of leukemia relapse after allogeneic hematopoietic stem cell transplantation in China
Yu Wang et al.
CANCER LETTERS (2018)
The role of collateral related donors in haploidentical hematopoietic stem cell transplantation
Xiao-Dong Mo et al.
SCIENCE BULLETIN (2018)
Evaluation of a disease risk index for adult patients undergoing umbilical cord blood transplantation for haematological malignancies
Annalisa Paviglianiti et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
Haploidentical Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndrome
Xiao-Dong Mo et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
A review of hematopoietic cell transplantation in China: data and trends during 2008-2016
L-P Xu et al.
BONE MARROW TRANSPLANTATION (2017)
Impact of Pretransplantation Indices in Hematopoietic Stem Cell Transplantation: Knowledge of Center-Specific Outcome Data Is Pivotal before Making Index-Based Decisions
Johan Torlen et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
The impact of HLA matching on outcomes of unmanipulated haploidentical HSCT is modulated by GVHD prophylaxis
Francesca Lorentino et al.
BLOOD ADVANCES (2017)
Haploidentical versus Matched-Sibling Transplant in Adults with Philadelphia-Negative High-Risk Acute Lymphoblastic Leukemia: A Biologically Phase III Randomized Study
Yu Wang et al.
CLINICAL CANCER RESEARCH (2016)
Haploidentical transplant for myelodysplastic syndrome: registry-based comparison with identical sibling transplant
Y. Wang et al.
LEUKEMIA (2016)
Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide
Shannon R. McCurdy et al.
BLOOD (2015)
Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study
Yu Wang et al.
BLOOD (2015)
Outcomes of Nonmyeloablative HLA-Haploidentical Blood or Marrow Transplantation With High-Dose Post-Transplantation Cyclophosphamide in Older Adults
Yvette L. Kasamon et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Validating the Allogeneic Stem Cell Transplantation Disease Risk Index: Sample Size, Follow-up, and Local Data Are Important
Andrew B. M. Lim et al.
TRANSPLANTATION (2015)
Haploidentical hematopoietic stem cell transplantation in adults with Philadelphia-negative acute lymphoblastic leukemia: No difference in the high-and low-risk groups
Xiao-Dong Mo et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Validation of the Disease Risk Index for Outcome of Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation after T Cell Depletion
Yan Beauverd et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Haploidentical transplantation: the search for the best donor
Rupert Handgretinger
BLOOD (2014)
Who is the best donor for a related HLA haplotype-mismatched transplant?
Yu Wang et al.
BLOOD (2014)
Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation
Philippe Armand et al.
BLOOD (2014)
EBMT risk score can predict the outcome of leukaemia after unmanipulated haploidentical blood and marrow transplantation
H-t Wang et al.
BONE MARROW TRANSPLANTATION (2014)
Comparison of Reduced-Intensity and Myeloablative Conditioning Regimens for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia: A Meta-Analysis
S. Fadilah Abdul Wahid et al.
STEM CELLS AND DEVELOPMENT (2014)
The hematopoietic cell transplantation-specific comorbidity index (HCT-CI) is an outcome predictor for partially matched related donor transplantation
Xiao-Dong Mo et al.
AMERICAN JOURNAL OF HEMATOLOGY (2013)
Haploidentical, unmanipulated, G-CSF-primed bone marrow transplantation for patients with high-risk hematologic malignancies
Paolo Di Bartolomeo et al.
BLOOD (2013)
Long-term follow-up of haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of leukemia Nine Years of Experience at a Single Center
Yu Wang et al.
CANCER (2013)
A disease risk index for patients undergoing allogeneic stem cell transplantation
Philippe Armand et al.
BLOOD (2012)
Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: a phase II study
Birgit Federmann et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Allogeneic hematopoietic stem cell transplantation in China: where we are and where to go
Meng Lv et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2012)
Unmanipulated HLA-Mismatched/Haploidentical Blood and Marrow Hematopoietic Stem Cell Transplantation
Xiao-Jun Huang et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
Reduced-intensity conditioning therapy with busulfan, fludarabine, and antithymocyte globulin for HLA-haploidentical hematopoietic cell transplantation in acute leukemia and myelodysplastic syndrome
Kyoo-Hyung Lee et al.
BLOOD (2011)
Hematopoietic cell transplantation comorbidity index predicts transplantation outcomes in pediatric patients
Angela R. Smith et al.
BLOOD (2011)
Comorbidity as prognostic variable in MDS: comparative evaluation of the HCT-CI and CCI in a core dataset of 419 patients of the Austrian MDS Study Group
W. R. Sperr et al.
ANNALS OF ONCOLOGY (2010)
Assessment of the Hematopoietic Cell Transplantation Comorbidity Index in Non-Hodgkin Lymphoma Patients Receiving Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation
Seth M. Pollack et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Treatment of Acute Leukemia with Unmanipulated HLA-Mismatched/Haploidentical Blood and Bone Marrow Transplantation
Xiao-Jun Huang et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide
Leo Luznik et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission at transplantation
Fabio Ciceri et al.
BLOOD (2008)
Hematopoietic cell transplantation-specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences
Mohamed L. Sorror et al.
BLOOD (2007)
Comorbidity and disease status-based risk stratification of outcomes among patients with acute myeloid leukemia or myelodysplasia receiving allogeneic hematopoietic cell transplantation
Mohamed L. Sorror et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
ML Sorror et al.
BLOOD (2005)
Share Paper
